MDxHealth SA Stock Euronext Bruxelles
Equities
MDXH
BE0974461940
Biotechnology & Medical Research
Sales 2023 | 64.39M 69.09M | Sales 2024 * | 77.22M 82.86M | Capitalization | 68.1M 73.07M |
---|---|---|---|---|---|
Net income 2023 | -39M -41.85M | Net income 2024 * | -26M -27.9M | EV / Sales 2023 | 1.51 x |
Net cash position 2023 * | - 0 | Net Debt 2024 * | 103.27 110.81 | EV / Sales 2024 * | 0.88 x |
P/E ratio 2023 |
-2.37
x | P/E ratio 2024 * |
-2.96
x | Employees | 255 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 97.37% |
Latest transcript on MDxHealth SA
1st Jan change | Capi. | |
---|---|---|
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |